- Prefilled syringes are ready-to-use injection devices that come pre-filled with a specific dosage of medication, offering convenience, safety, and reduced risk of dosing errors. They are widely used for biologics, vaccines, and chronic condition treatments
- The demand for prefilled syringes is significantly driven by the increasing adoption of biologics, self-administration of injectable drugs, and the growing prevalence of chronic diseases such as diabetes
- North America is expected to dominate the prefilled syringes market with a market share of 32.5%, due to advanced healthcare infrastructure, widespread adoption of injectable biologics, and the high prevalence of chronic diseases such as diabetes and rheumatoid arthritis
- Asia-Pacific is expected to be the fastest growing region in the prefilled syringes market with a market share of 25.3%, during the forecast period due to rapid healthcare infrastructure development, increased focus on chronic disease management, and rising healthcare awareness
- Glass prefilled syringes segment is expected to dominate the market with a market share of 50.9% due to its superior chemical resistance, excellent barrier properties, and compatibility with a wide range of drug formulations, including biologics.
